Trial Profile

The Study About Glucose Lowering Effect of Vildagliptin in Type 2 Diabetes Patients Treated With Metformin and a Sulfonylurea.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vildagliptin (Primary) ; Glimepiride; Metformin
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms VISUAL

Most Recent Events

27 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
14 Mar 2014 Planned number of patients changed from 230 to 400, as per ClinicalTrials.gov record.
10 Jan 2014 Planned End Date changed from 1 Jul 2012 to 1 Jul 2014 according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com